 | • レポートコード：GIR201114980 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、放射免疫療法の世界市場を調査対象にし、放射免疫療法の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（非ホジキンリンパ腫（NHL）、濾胞性リンパ腫、固形腫瘍、乳がん、卵巣がん、骨肉腫、神経芽細胞腫、前立腺がん）、用途別分析（腫瘍抗原、放射性核種、抗体）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Bayer Healthcare Pharmaceuticals、Nordic Nanovector、Curasight、BioSynthema、Molecular Insight Pharmaceuticals、Clarity Pharmaceuticals、Philogen、Immunomedics、Endocyte、PDL Biopharma、RadioMedix、Stella Pharma、Telix Pharmaceuticals ・企業別売上、市場シェア ・放射免疫療法の地域別市場分析 ・放射免疫療法の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・放射免疫療法のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・放射免疫療法のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・放射免疫療法の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・放射免疫療法の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・放射免疫療法の種類別市場規模2015-2020：非ホジキンリンパ腫（NHL）、濾胞性リンパ腫、固形腫瘍、乳がん、卵巣がん、骨肉腫、神経芽細胞腫、前立腺がん ・放射免疫療法の用途別市場規模2015-2020：腫瘍抗原、放射性核種、抗体 ・放射免疫療法の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Radioimmunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Radioimmunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Radioimmunotherapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Radioimmunotherapy market has been segmented into:
Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma
Solid Tumors
Breast Cancer
Ovarian Cancer
Osteosarcoma
Neuroblastoma
Prostate Cancer
By Application, Radioimmunotherapy has been segmented into:
Tumor Antigens
Radionuclides
Antibodies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Radioimmunotherapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Radioimmunotherapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Radioimmunotherapy market.
The report offers in-depth assessment of the growth and other aspects of the Radioimmunotherapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Radioimmunotherapy Market Share Analysis
Radioimmunotherapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Radioimmunotherapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Radioimmunotherapy sales, revenue and market share for each player covered in this report.
The major players covered in Radioimmunotherapy are:
Bayer Healthcare Pharmaceuticals
Nordic Nanovector
Curasight
BioSynthema
Molecular Insight Pharmaceuticals
Clarity Pharmaceuticals
Philogen
Immunomedics
Endocyte
PDL Biopharma
RadioMedix
Stella Pharma
Telix Pharmaceuticals
Table of Contents
1 Radioimmunotherapy Market Overview
1.1 Product Overview and Scope of Radioimmunotherapy
1.2 Classification of Radioimmunotherapy by Type
1.2.1 Global Radioimmunotherapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Radioimmunotherapy Revenue Market Share by Type in 2019
1.2.3 Non Hodgkin Lymphoma (NHL)
1.2.4 Follicular Lymphoma
1.2.5 Solid Tumors
1.2.6 Breast Cancer
1.2.7 Ovarian Cancer
1.2.8 Osteosarcoma
1.2.9 Neuroblastoma
1.2.10 Prostate Cancer
1.3 Global Radioimmunotherapy Market by Application
1.3.1 Overview: Global Radioimmunotherapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Tumor Antigens
1.3.3 Radionuclides
1.3.4 Antibodies
1.4 Global Radioimmunotherapy Market by Regions
1.4.1 Global Radioimmunotherapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Radioimmunotherapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Radioimmunotherapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Radioimmunotherapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Radioimmunotherapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Radioimmunotherapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Radioimmunotherapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bayer Healthcare Pharmaceuticals
2.1.1 Bayer Healthcare Pharmaceuticals Details
2.1.2 Bayer Healthcare Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer Healthcare Pharmaceuticals SWOT Analysis
2.1.4 Bayer Healthcare Pharmaceuticals Product and Services
2.1.5 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nordic Nanovector
2.2.1 Nordic Nanovector Details
2.2.2 Nordic Nanovector Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nordic Nanovector SWOT Analysis
2.2.4 Nordic Nanovector Product and Services
2.2.5 Nordic Nanovector Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Curasight
2.3.1 Curasight Details
2.3.2 Curasight Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Curasight SWOT Analysis
2.3.4 Curasight Product and Services
2.3.5 Curasight Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioSynthema
2.4.1 BioSynthema Details
2.4.2 BioSynthema Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioSynthema SWOT Analysis
2.4.4 BioSynthema Product and Services
2.4.5 BioSynthema Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Molecular Insight Pharmaceuticals
2.5.1 Molecular Insight Pharmaceuticals Details
2.5.2 Molecular Insight Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Molecular Insight Pharmaceuticals SWOT Analysis
2.5.4 Molecular Insight Pharmaceuticals Product and Services
2.5.5 Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Clarity Pharmaceuticals
2.6.1 Clarity Pharmaceuticals Details
2.6.2 Clarity Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Clarity Pharmaceuticals SWOT Analysis
2.6.4 Clarity Pharmaceuticals Product and Services
2.6.5 Clarity Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Philogen
2.7.1 Philogen Details
2.7.2 Philogen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Philogen SWOT Analysis
2.7.4 Philogen Product and Services
2.7.5 Philogen Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Immunomedics
2.8.1 Immunomedics Details
2.8.2 Immunomedics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Immunomedics SWOT Analysis
2.8.4 Immunomedics Product and Services
2.8.5 Immunomedics Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Endocyte
2.9.1 Endocyte Details
2.9.2 Endocyte Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Endocyte SWOT Analysis
2.9.4 Endocyte Product and Services
2.9.5 Endocyte Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 PDL Biopharma
2.10.1 PDL Biopharma Details
2.10.2 PDL Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 PDL Biopharma SWOT Analysis
2.10.4 PDL Biopharma Product and Services
2.10.5 PDL Biopharma Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 RadioMedix
2.11.1 RadioMedix Details
2.11.2 RadioMedix Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 RadioMedix SWOT Analysis
2.11.4 RadioMedix Product and Services
2.11.5 RadioMedix Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Stella Pharma
2.12.1 Stella Pharma Details
2.12.2 Stella Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Stella Pharma SWOT Analysis
2.12.4 Stella Pharma Product and Services
2.12.5 Stella Pharma Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Telix Pharmaceuticals
2.13.1 Telix Pharmaceuticals Details
2.13.2 Telix Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Telix Pharmaceuticals SWOT Analysis
2.13.4 Telix Pharmaceuticals Product and Services
2.13.5 Telix Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Radioimmunotherapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Radioimmunotherapy Players Market Share
3.2.2 Top 10 Radioimmunotherapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Radioimmunotherapy Revenue and Market Share by Regions
4.2 North America Radioimmunotherapy Revenue and Growth Rate (2015-2020)
4.3 Europe Radioimmunotherapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Radioimmunotherapy Revenue and Growth Rate (2015-2020)
4.5 South America Radioimmunotherapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Radioimmunotherapy Revenue and Growth Rate (2015-2020)
5 North America Radioimmunotherapy Revenue by Countries
5.1 North America Radioimmunotherapy Revenue by Countries (2015-2020)
5.2 USA Radioimmunotherapy Revenue and Growth Rate (2015-2020)
5.3 Canada Radioimmunotherapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Radioimmunotherapy Revenue and Growth Rate (2015-2020)
6 Europe Radioimmunotherapy Revenue by Countries
6.1 Europe Radioimmunotherapy Revenue by Countries (2015-2020)
6.2 Germany Radioimmunotherapy Revenue and Growth Rate (2015-2020)
6.3 UK Radioimmunotherapy Revenue and Growth Rate (2015-2020)
6.4 France Radioimmunotherapy Revenue and Growth Rate (2015-2020)
6.5 Russia Radioimmunotherapy Revenue and Growth Rate (2015-2020)
6.6 Italy Radioimmunotherapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Radioimmunotherapy Revenue by Countries
7.1 Asia-Pacific Radioimmunotherapy Revenue by Countries (2015-2020)
7.2 China Radioimmunotherapy Revenue and Growth Rate (2015-2020)
7.3 Japan Radioimmunotherapy Revenue and Growth Rate (2015-2020)
7.4 Korea Radioimmunotherapy Revenue and Growth Rate (2015-2020)
7.5 India Radioimmunotherapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Radioimmunotherapy Revenue and Growth Rate (2015-2020)
8 South America Radioimmunotherapy Revenue by Countries
8.1 South America Radioimmunotherapy Revenue by Countries (2015-2020)
8.2 Brazil Radioimmunotherapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Radioimmunotherapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Radioimmunotherapy by Countries
9.1 Middle East & Africa Radioimmunotherapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Radioimmunotherapy Revenue and Growth Rate (2015-2020)
9.3 UAE Radioimmunotherapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Radioimmunotherapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Radioimmunotherapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Radioimmunotherapy Revenue and Market Share by Type (2015-2020)
10.2 Global Radioimmunotherapy Market Forecast by Type (2019-2024)
10.3 Non Hodgkin Lymphoma (NHL) Revenue Growth Rate (2015-2025)
10.4 Follicular Lymphoma Revenue Growth Rate (2015-2025)
10.5 Solid Tumors Revenue Growth Rate (2015-2025)
10.6 Breast Cancer Revenue Growth Rate (2015-2025)
10.7 Ovarian Cancer Revenue Growth Rate (2015-2025)
10.8 Osteosarcoma Revenue Growth Rate (2015-2025)
10.9 Neuroblastoma Revenue Growth Rate (2015-2025)
10.10 Prostate Cancer Revenue Growth Rate (2015-2025)
11 Global Radioimmunotherapy Market Segment by Application
11.1 Global Radioimmunotherapy Revenue Market Share by Application (2015-2020)
11.2 Radioimmunotherapy Market Forecast by Application (2019-2024)
11.3 Tumor Antigens Revenue Growth (2015-2020)
11.4 Radionuclides Revenue Growth (2015-2020)
11.5 Antibodies Revenue Growth (2015-2020)
12 Global Radioimmunotherapy Market Size Forecast (2021-2025)
12.1 Global Radioimmunotherapy Market Size Forecast (2021-2025)
12.2 Global Radioimmunotherapy Market Forecast by Regions (2021-2025)
12.3 North America Radioimmunotherapy Revenue Market Forecast (2021-2025)
12.4 Europe Radioimmunotherapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Radioimmunotherapy Revenue Market Forecast (2021-2025)
12.6 South America Radioimmunotherapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Radioimmunotherapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Radioimmunotherapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Radioimmunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Radioimmunotherapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Radioimmunotherapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bayer Healthcare Pharmaceuticals Corporate Information, Location and Competitors
Table 6. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Major Business
Table 7. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 8. Bayer Healthcare Pharmaceuticals SWOT Analysis
Table 9. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product and Solutions
Table 10. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Nordic Nanovector Corporate Information, Location and Competitors
Table 12. Nordic Nanovector Radioimmunotherapy Major Business
Table 13. Nordic Nanovector Radioimmunotherapy Total Revenue (USD Million) (2018-2019)
Table 14. Nordic Nanovector SWOT Analysis
Table 15. Nordic Nanovector Radioimmunotherapy Product and Solutions
Table 16. Nordic Nanovector Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Curasight Corporate Information, Location and Competitors
Table 18. Curasight Radioimmunotherapy Major Business
Table 19. Curasight Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 20. Curasight SWOT Analysis
Table 21. Curasight Radioimmunotherapy Product and Solutions
Table 22. Curasight Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BioSynthema Corporate Information, Location and Competitors
Table 24. BioSynthema Radioimmunotherapy Major Business
Table 25. BioSynthema Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 26. BioSynthema SWOT Analysis
Table 27. BioSynthema Radioimmunotherapy Product and Solutions
Table 28. BioSynthema Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Molecular Insight Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Molecular Insight Pharmaceuticals Radioimmunotherapy Major Business
Table 31. Molecular Insight Pharmaceuticals Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 32. Molecular Insight Pharmaceuticals SWOT Analysis
Table 33. Molecular Insight Pharmaceuticals Radioimmunotherapy Product and Solutions
Table 34. Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Clarity Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Clarity Pharmaceuticals Radioimmunotherapy Major Business
Table 37. Clarity Pharmaceuticals Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 38. Clarity Pharmaceuticals SWOT Analysis
Table 39. Clarity Pharmaceuticals Radioimmunotherapy Product and Solutions
Table 40. Clarity Pharmaceuticals Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Philogen Corporate Information, Location and Competitors
Table 42. Philogen Radioimmunotherapy Major Business
Table 43. Philogen Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 44. Philogen SWOT Analysis
Table 45. Philogen Radioimmunotherapy Product and Solutions
Table 46. Philogen Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Immunomedics Corporate Information, Location and Competitors
Table 48. Immunomedics Radioimmunotherapy Major Business
Table 49. Immunomedics Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 50. Immunomedics SWOT Analysis
Table 51. Immunomedics Radioimmunotherapy Product and Solutions
Table 52. Immunomedics Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Endocyte Corporate Information, Location and Competitors
Table 54. Endocyte Radioimmunotherapy Major Business
Table 55. Endocyte Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 56. Endocyte SWOT Analysis
Table 57. Endocyte Radioimmunotherapy Product and Solutions
Table 58. Endocyte Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. PDL Biopharma Corporate Information, Location and Competitors
Table 60. PDL Biopharma Radioimmunotherapy Major Business
Table 61. PDL Biopharma Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 62. PDL Biopharma SWOT Analysis
Table 63. PDL Biopharma Radioimmunotherapy Product and Solutions
Table 64. PDL Biopharma Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. RadioMedix Corporate Information, Location and Competitors
Table 66. RadioMedix Radioimmunotherapy Major Business
Table 67. RadioMedix Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 68. RadioMedix SWOT Analysis
Table 69. RadioMedix Radioimmunotherapy Product and Solutions
Table 70. RadioMedix Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Stella Pharma Corporate Information, Location and Competitors
Table 72. Stella Pharma Radioimmunotherapy Major Business
Table 73. Stella Pharma Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 74. Stella Pharma SWOT Analysis
Table 75. Stella Pharma Radioimmunotherapy Product and Solutions
Table 76. Stella Pharma Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Telix Pharmaceuticals Corporate Information, Location and Competitors
Table 78. Telix Pharmaceuticals Radioimmunotherapy Major Business
Table 79. Telix Pharmaceuticals Radioimmunotherapy Total Revenue (USD Million) (2017-2018)
Table 80. Telix Pharmaceuticals SWOT Analysis
Table 81. Telix Pharmaceuticals Radioimmunotherapy Product and Solutions
Table 82. Telix Pharmaceuticals Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Radioimmunotherapy Revenue (Million USD) by Players (2015-2020)
Table 84. Global Radioimmunotherapy Revenue Share by Players (2015-2020)
Table 85. Global Radioimmunotherapy Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Radioimmunotherapy Revenue Market Share by Regions (2015-2020)
Table 87. North America Radioimmunotherapy Revenue by Countries (2015-2020)
Table 88. North America Radioimmunotherapy Revenue Market Share by Countries (2015-2020)
Table 89. Europe Radioimmunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Radioimmunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Radioimmunotherapy Revenue by Countries (2015-2020)
Table 92. South America Radioimmunotherapy Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Radioimmunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Radioimmunotherapy Revenue Market Share by Countries (2015-2020)
Table 95. Global Radioimmunotherapy Revenue (Million USD) by Type (2015-2020)
Table 96. Global Radioimmunotherapy Revenue Share by Type (2015-2020)
Table 97. Global Radioimmunotherapy Revenue Forecast by Type (2021-2025)
Table 98. Global Radioimmunotherapy Revenue by Application (2015-2020)
Table 99. Global Radioimmunotherapy Revenue Share by Application (2015-2020)
Table 100. Global Radioimmunotherapy Revenue Forecast by Application (2021-2025)
Table 101. Global Radioimmunotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Radioimmunotherapy Picture
Figure 2. Global Radioimmunotherapy Revenue Market Share by Type in 2019
Figure 3. Non Hodgkin Lymphoma (NHL) Picture
Figure 4. Follicular Lymphoma Picture
Figure 5. Solid Tumors Picture
Figure 6. Breast Cancer Picture
Figure 7. Ovarian Cancer Picture
Figure 8. Osteosarcoma Picture
Figure 9. Neuroblastoma Picture
Figure 10. Prostate Cancer Picture
Figure 11. Radioimmunotherapy Revenue Market Share by Application in 2019
Figure 12. Tumor Antigens Picture
Figure 13. Radionuclides Picture
Figure 14. Antibodies Picture
Figure 15. Global Radioimmunotherapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Radioimmunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Radioimmunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Radioimmunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Radioimmunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Radioimmunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Radioimmunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Radioimmunotherapy Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Radioimmunotherapy Revenue Market Share in 2019
Figure 24. Global Top 10 Players Radioimmunotherapy Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Radioimmunotherapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Radioimmunotherapy Revenue Market Share by Regions (2015-2020)
Figure 28. Global Radioimmunotherapy Revenue Market Share by Regions in 2018
Figure 29. North America Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 30. Europe Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 32. South America Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 34. North America Radioimmunotherapy Revenue Market Share by Countries (2015-2020)
Figure 35. North America Radioimmunotherapy Revenue Market Share by Countries in 2019
Figure 36. USA Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 37. Canada Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 39. Europe Radioimmunotherapy Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Radioimmunotherapy Revenue Market Share by Countries in 2019
Figure 41. Germany Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 42. UK Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 43. France Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 44. Russia Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 45. Italy Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Radioimmunotherapy Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Radioimmunotherapy Revenue Market Share by Countries in 2019
Figure 48. China Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 49. Japan Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 50. Korea Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 51. India Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 53. South America Radioimmunotherapy Revenue Market Share by Countries (2015-2020)
Figure 54. South America Radioimmunotherapy Revenue Market Share by Countries in 2019
Figure 55. Brazil Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Radioimmunotherapy Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Radioimmunotherapy Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 60. UAE Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Radioimmunotherapy Revenue and Growth Rate (2015-2020)
Figure 63. Global Radioimmunotherapy Revenue Share by Type (2015-2020)
Figure 64. Global Radioimmunotherapy Revenue Share by Type in 2019
Figure 65. Global Radioimmunotherapy Market Share Forecast by Type (2021-2025)
Figure 66. Global Non Hodgkin Lymphoma (NHL) Revenue Growth Rate (2015-2020)
Figure 67. Global Follicular Lymphoma Revenue Growth Rate (2015-2020)
Figure 68. Global Solid Tumors Revenue Growth Rate (2015-2020)
Figure 69. Global Breast Cancer Revenue Growth Rate (2015-2020)
Figure 70. Global Ovarian Cancer Revenue Growth Rate (2015-2020)
Figure 71. Global Osteosarcoma Revenue Growth Rate (2015-2020)
Figure 72. Global Neuroblastoma Revenue Growth Rate (2015-2020)
Figure 73. Global Prostate Cancer Revenue Growth Rate (2015-2020)
Figure 74. Global Radioimmunotherapy Revenue Share by Application (2015-2020)
Figure 75. Global Radioimmunotherapy Revenue Share by Application in 2019
Figure 76. Global Radioimmunotherapy Market Share Forecast by Application (2021-2025)
Figure 77. Global Tumor Antigens Revenue Growth Rate (2015-2020)
Figure 78. Global Radionuclides Revenue Growth Rate (2015-2020)
Figure 79. Global Antibodies Revenue Growth Rate (2015-2020)
Figure 80. Global Radioimmunotherapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Radioimmunotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Radioimmunotherapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Radioimmunotherapy Revenue Market Forecast (2021-2025)
Figure 84. Europe Radioimmunotherapy Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Radioimmunotherapy Revenue Market Forecast (2021-2025)
Figure 86. South America Radioimmunotherapy Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Radioimmunotherapy Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
乳がん診断技術の世界市場 2020年 Market Overview The global Breast Cancer Diagnostic Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast …- 卵巣がん診断技術の世界市場 2020年 Market Overview The global Ovarian Cancer Diagnostics Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovari…
- 乳がんスクリーニングの世界市場 2020年 Market Overview The Breast Cancer Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 乳がん治療薬の世界市場 2020年 Market Overview The global Breast Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast Cancer T…
- 転移性卵巣がん治療薬の世界市場 2020年 Market Overview The global Metastatic Ovarian Cancer Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic Ova…